OOIR: Observatory of International Research

Papers

(The TQCC of Emerging Infectious Diseases is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-08-01 to 2024-08-01.)

Article	Citations
US CDC Real-Time Reverse Transcription PCR Panel for Detection of Severe Acute Respiratory Syndrome Coronavirus 2	522
Infectious SARS-CoV-2 in Feces of Patient with Severe COVID-19	429
Coronavirus Disease Outbreak in Call Center, South Korea	396
Contact Tracing during Coronavirus Disease Outbreak, South Korea, 2020	391
Evaluating the Effectiveness of Social Distancing Interventions to Delay or Flatten the Epidemic Curve of Coronavirus Disease	324
Estimating the Frequency of Lyme Disease Diagnoses, United States, 2010–2018	322
Multicenter Epidemiologic Study of Coronavirus Disease–Associated Mucormycosis, India	315
Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease, United States	310
Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 in Aerosol Suspensions	256
Decreased Influenza Incidence under COVID-19 Control Measures, Singapore	240
SARS-CoV-2 Transmission between Mink (Neovison vison) and Humans, Denmark	230
Multidrug-Resistant Candida auris Infections in Critically Ill Coronavirus Disease Patients, India, April–July 2020	226
Cluster of Coronavirus Disease Associated with Fitness Dance Classes, South Korea	206
Imported Monkeypox, Singapore	200
Estimate of Burden and Direct Healthcare Cost of Infectious Waterborne Disease in the United States	199
SARS-CoV-2 Virus Culture and Subgenomic RNA for Respiratory Specimens from Patients with Mild Coronavirus Disease	194
Clusters of Coronavirus Disease in Communities, Japan, January–April 2020	182
COVID-19–Associated Pulmonary Aspergillosis, March–August 2020	181
Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil	169
Effectiveness of N95 Respirator Decontamination and Reuse against SARS-CoV-2 Virus	169
Monitoring SARS-CoV-2 Circulation and Diversity through Community Wastewater Sequencing, the Netherlands and Belgium	167
Prolonged Infectivity of SARS-CoV-2 in Fomites	163
Transmission of SARS-CoV 2 During Long-Haul Flight	163
Reemergence of Human Monkeypox and Declining Population Immunity in the Context of Urbanization, Nigeria, 2017–2020	162
Case-Control Study of Use of Personal Protective Measures and Risk for SARS-CoV 2 Infection, Thailand	157

Viral RNA Load in Mildly Symptomatic and Asymptomatic Children with COVID-19, Seoul, South Korea	155
Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France	155
Imported Monkeypox from International Traveler, Maryland, USA, 2021	151
SARS-CoV-2 in Quarantined Domestic Cats from COVID-19 Households or Close Contacts, Hong Kong, China	148
Probable Transmission of SARS-CoV-2 Omicron Variant in Quarantine Hotel, Hong Kong, China, November 2021	148
Novel SARS-CoV-2 Variant in Travelers from Brazil to Japan	147
Resurgence of Respiratory Syncytial Virus Infections during COVID-19 Pandemic, Tokyo, Japan	147
SARS-CoV-2 Natural Transmission from Human to Cat, Belgium, March 2020	146
Prolonged Persistence of SARS-CoV-2 RNA in Body Fluids	143
Effect of Environmental Conditions on SARS-CoV-2 Stability in Human Nasal Mucus and Sputum	139
Experimental Infection of Cattle with SARS-CoV-2	138
Encephalopathy and Encephalitis Associated with Cerebrospinal Fluid Cytokine Alterations and Coronavirus Disease, Atlanta, Georgia, USA, 2020	138
Susceptibility of Raccoon Dogs for Experimental SARS-CoV-2 Infection	134
Viral Interference between Respiratory Viruses	133
Aspergillosis Complicating Severe Coronavirus Disease	132
Detection and Characterization of Bat Sarbecovirus Phylogenetically Related to SARS-CoV-2, Japan	121
Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January–April 2020	120
Rapid, Sensitive, Full-Genome Sequencing of Severe Acute Respiratory Syndrome Coronavirus 2	118
Clinicopathologic and Immunohistochemical Findings from Autopsy of Patient with COVID-19, Japan	117
Comparison of Lyme Disease in the United States and Europe	114
Isolation, Sequence, Infectivity, and Replication Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2	112
Intercontinental Movement of Highly Pathogenic Avian Influenza A(H5N1) Clade 2.3.4.4 Virus to the United States, 2021	110
Culture-Competent SARS-CoV-2 in Nasopharynx of Symptomatic Neonates, Children, and Adolescents	109
Suspected Cat-to-Human Transmission of SARS-CoV-2, Thailand, July–September 2021	107
Collateral Benefit of COVID-19 Control Measures on Influenza Activity, Taiwan	105
Epidemiologic Evidence for Airborne Transmission of SARS-CoV-2 during Church Singing, Australia, 2020	103
Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection	101
Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity	100
Coronavirus Disease among Workers in Food Processing, Food Manufacturing, and Agriculture Workplaces	98
Antibody Responses 8 Months after Asymptomatic or Mild SARS-CoV-2 Infection	95
Global Trends in Norovirus Genotype Distribution among Children with Acute Gastroenteritis	95
Coronavirus Disease among Persons with Sickle Cell Disease, United States, March 20–May 21, 2020	94
Multinational Observational Cohort Study of COVID-19–Associated Pulmonary Aspergillosis1	93
Population-Based Estimates of Chronic Conditions Affecting Risk for Complications from Coronavirus Disease, United States	92
Highly Pathogenic Avian Influenza A(H5N1) Virus Outbreak in New England Seals, United States	91
Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2–Specific IgG	91
Asymptomatic Transmission of SARS-CoV-2 on Evacuation Flight	90
Detection of Severe Acute Respiratory Syndrome Coronavirus 2 RNA on Surfaces in Quarantine Rooms	89
Epidemiology of Infections with SARS-CoV-2 Omicron BA.2 Variant, Hong Kong, January–March 2022	89
Effectiveness of Cloth Masks for Protection Against Severe Acute Respiratory Syndrome Coronavirus 2	86
Anopheles stephensi Mosquitoes as Vectors of Plasmodiumvivax and falciparum, Horn of Africa, 2019	82
Impact of Social Distancing Measures on Coronavirus Disease Healthcare Demand, Central Texas, USA	82
Susceptibility of Domestic Swine to Experimental Infection with Severe Acute Respiratory Syndrome Coronavirus 2	82
Herd Immunity against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 10 Communities, Qatar	80
Addressing COVID-19 Misinformation on Social Media Preemptively and Responsively	80
Clinical Evaluation of Roche SD Biosensor Rapid Antigen Test for SARS-CoV-2 in Municipal Health Service Testing Site, the Netherlands	79
SARS-CoV-2 Exposure in Escaped Mink, Utah, USA	78
Genotypic Heterogeneity of Orientia tsutsugamushi in Scrub Typhus Patients and Thrombocytopenia Syndrome Co-infection, Myanmar	77
SARS-CoV-2 Seroprevalence in a Rural and Urban Household Cohort during First and Second Waves of Infections, South Africa, July 2020–March 2021	77
SARS-CoV-2 Wastewater Surveillance for Public Health Action	76

Use of Commercial Claims Data for Evaluating Trends in Lyme Disease Diagnoses, United States, 2010–2018	75
Sensitive Detection of SARS-CoV-2–Specific Antibodies in Dried Blood Spot Samples	75
Clostridioides difficile in COVID-19 Patients, Detroit, Michigan, USA, March–April 2020	75
Lessons Learned from a Decade of Investigations of Shiga Toxin–Producing Escherichia coli Outbreaks Linked to Leafy Greens, United States and Canada	70
Multisystem Inflammatory Syndrome after SARS-CoV-2 Infection and COVID-19 Vaccination	70
Pulmonary Embolism and Increased Levels of d-Dimer in Patients with Coronavirus Disease	70
Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 during Border Quarantine and Air Travel, New Zealand (Aotearoa)	70
Extensive Dermatophytosis Caused by Terbinafine-Resistant Trichophyton indotineae, France	69
SARS-CoV-2 Delta Variant among Asiatic Lions, India	68
Rapid Spread and Control of Multidrug-Resistant Gram-Negative Bacteria in COVID-19 Patient Care Units	66
Impact of a Nationwide Lockdown on SARS-CoV-2 Transmissibility, Italy	66
Secondary Attack Rate, Transmission and Incubation Periods, and Serial Interval of SARS-CoV-2 Omicron Variant, Spain	66
Postvaccination COVID-19 among Healthcare Workers, Israel	66
Lack of Susceptibility to SARS-CoV-2 and MERS-CoV in Poultry	66
Seroepidemiologic Study Designs for Determining SARS-COV-2 Transmission and Immunity	65
Molecular Description of a Novel Orientia Species Causing Scrub Typhus in Chile	64
Correlates of Protection, Thresholds of Protection, and Immunobridging among Persons with SARS-CoV-2 Infection	64
Flight-Associated Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Corroborated by Whole-Genome Sequencing	64
Limited Specificity of Serologic Tests for SARS-CoV-2 Antibody Detection, Benin	63
Highly Pathogenic Avian Influenza A(H5N1) Virus in Wild Red Foxes, the Netherlands, 2021	63
Epidemiology of Early Monkeypox Virus Transmission in Sexual Networks of Gay and Bisexual Men, England, 2022	63
Delayed Antibody and T-Cell Response to BNT162b2 Vaccination in the Elderly, Germany	63
COVID-19 and Infant Hospitalizations for Seasonal Respiratory Virus Infections, New Zealand, 2020	63
Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March–April 2020	62
In-Flight Transmission of SARS-CoV-2	62
Secondary Transmission of Coronavirus Disease from Presymptomatic Persons, China	62
Emergence of SARS-COV-2 Spike Protein Escape Mutation Q493R after Treatment for COVID-19	61
Coronavirus Disease Exposure and Spread from Nightclubs, South Korea	61
Genomic Evidence of In-Flight Transmission of SARS-CoV-2 Despite Predeparture Testing	61
Evidence of SARS-CoV-2 RNA in an Oropharyngeal Swab Specimen, Milan, Italy, Early December 2019	61
Direct Transmission of Severe Fever with Thrombocytopenia Syndrome Virus from Domestic Cat to Veterinary Personnel	61
Stability of SARS-CoV-2 RNA in Nonsupplemented Saliva	60
Effectiveness of BNT162b2 Vaccine in Adolescents during Outbreak of SARS-CoV-2 Delta Variant Infection, Israel, 2021	60
Environmental Persistence of Monkeypox Virus on Surfaces in Household of Person with Travel-Associated Infection, Dallas, Texas, USA, 2021	60
Doubling Time of the COVID-19 Epidemic by Province, China	60
Characteristics of SARS-CoV-2 Transmission among Meat Processing Workers in Nebraska, USA, and Effectiveness of Risk Mitigation Measures	60
Asymptomatic SARS-CoV-2 Infection in Household Contacts of a Healthcare Provider, Wuhan, China	59
Peridomestic Mammal Susceptibility to Severe Acute Respiratory Syndrome Coronavirus 2 Infection	59
Encephalitis and Death in Wild Mammals at a Rehabilitation Center after Infection with Highly Pathogenic Avian Influenza A(H5N8) Virus, United Kingdom	59
Effects of Coronavirus Disease Pandemic on Tuberculosis Notifications, Malawi	58
Natural SARS-CoV-2 Infection in Kept Ferrets, Spain	58
Serial Intervals and Household Transmission of SARS-CoV-2 Omicron Variant, South Korea, 2021	58
Analysis of SARS-CoV-2 Transmission in Different Settings, Brunei	58
COVID-19 Outbreak Associated with Air Conditioning in Restaurant, Guangzhou, China, 2020	57
Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant–Infected Vaccinees	57
Natural Human Infections with Plasmodium cynomolgi, P. inui, and 4 other Simian Malaria Parasites, Malaysia	57
Increased Incidence of Invasive Pneumococcal Disease among Children after COVID-19 Pandemic, England	56
SARS-CoV-2 Seroprevalence among Healthcare, First Response, and Public Safety Personnel, Detroit Metropolitan Area, Michigan, USA, May–June 2020	56
Increase in Kelch 13 Polymorphisms in Plasmodium falciparum, Southern Rwanda	56
Early Estimates of Monkeypox Incubation Period, Generation Time, and Reproduction Number, Italy, May–June 2022	56
Reflections on 40 Years of AIDS	56
Antibody Responses to SARS-CoV-2 at 8 Weeks Postinfection in Asymptomatic Patients	55
Serotype Replacement after Introduction of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines in 10 Countries, Europe	55
Trends in Viral Respiratory Infections During COVID-19 Pandemic, South Korea	55
SARS-CoV-2 Transmission from Presymptomatic Meeting Attendee, Germany	55
Effect of COVID-19 on Tuberculosis Notification, South Korea	54
Effects of Proactive Social Distancing on COVID-19 Outbreaks in 58 Cities, China	53
Local Transmission of SARS-CoV-2 Lineage B.1.1.7, Brazil, December 2020	53
High Proportion of Asymptomatic SARS-CoV-2 Infections in 9 Long-Term Care Facilities, Pasadena, California, USA, April 2020	52
Severe Acute Respiratory Syndrome Coronavirus 2 and Pregnancy Outcomes According to Gestational Age at Time of Infection	52
Clinical Course of Asymptomatic and Mildly Symptomatic Patients with Coronavirus Disease Admitted to Community Treatment Centers, South Korea	52
Parotitis-Like Symptoms Associated with COVID-19, France, March–April 2020	52
Serologic Screening of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Cats and Dogs during First Coronavirus Disease Wave, the Netherlands	52
Large Outbreak of Coronavirus Disease among Wedding Attendees, Jordan	51
Epidemiologic Features and Control Measures during Monkeypox Outbreak, Spain, June 2022	50
Updated Estimates and Mapping for Prevalence of Chagas Disease among Adults, United States	50
Panton-Valentine Leukocidin–Secreting Staphylococcus aureus Pneumonia Complicating COVID-19	49
Naturally Acquired Human Plasmodium cynomolgi and P. knowlesi Infections, Malaysian Borneo	49
Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020	49
Predictors of Nonseroconversion after SARS-CoV-2 Infection	48
Increased Incidence of Antimicrobial-Resistant Nontyphoidal Salmonella Infections, United States, 2004–2016	48
Effects of COVID-19 Prevention Measures on Other Common Infections, Taiwan	47
Evaluation of Commercially Available High-Throughput SARS-CoV-2 Serologic Assays for Serosurveillance and Related Applications	47
Incidence of Acute Rheumatic Fever and Rheumatic Heart Disease among Ethnic Groups, New Zealand, 2000–2018	47
Difficulties in Differentiating Coronaviruses from Subcellular Structures in Human Tissues by Electron Microscopy	47
Guillain-Barré Syndrome Associated with COVID-19 Vaccination	45
Animal Reservoirs and Hosts for Emerging Alphacoronaviruses and Betacoronaviruses	45
Early Insights from Statistical and Mathematical Modeling of Key Epidemiologic Parameters of COVID-19	45
SARS-CoV-2 Neutralization Resistance Mutations in Patient with HIV/AIDS, California, USA	45
Genomic Epidemiology of Global Carbapenemase-Producing Escherichia coli, 2015–2017	45

Severe Acute Respiratory Syndrome Coronavirus 2 P.2 Lineage Associated with Reinfection Case, Brazil, June–October 2020	45
Highly Pathogenic Avian Influenza A(H5N1) Clade 2.3.4.4b Virus Infection in Domestic Dairy Cattle and Cats, United States, 2024	44
Delayed Laboratory Response to COVID-19 Caused by Molecular Diagnostic Contamination	44
Multiplex Real-Time Reverse Transcription PCR for Influenza A Virus, Influenza B Virus, and Severe Acute Respiratory Syndrome Coronavirus 2	44
Superspreading Event of SARS-CoV-2 Infection at a Bar, Ho Chi Minh City, Vietnam	44
Saliva Alternative to Upper Respiratory Swabs for SARS-CoV-2 Diagnosis	44
Active Case Finding of Current Bornavirus Infections in Human Encephalitis Cases of Unknown Etiology, Germany, 2018–2020	44
Effect of Nonpharmaceutical Interventions on Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, South Korea, 2020	43
Emergence of Difficult-to-Treat Tinea Corporis Caused by Trichophyton mentagrophytes Complex Isolates, Paris, France	42
Invasive Malaria Vector Anopheles stephensi Mosquitoes in Sudan, 2016–2018	42
COVID-19–Associated Mold Infection in Critically Ill Patients, Chile	41
Nationwide External Quality Assessment of SARS-CoV-2 Molecular Testing, South Korea	41
Increased Detection of Carbapenemase-Producing Enterobacterales Bacteria in Latin America and the Caribbean during the COVID-19 Pandemic	41
Developing Endemicity of Schistosomiasis, Corsica, France	41
Multicenter Case–Control Study of COVID-19–Associated Mucormycosis Outbreak, India	41
Imported SARS-CoV-2 Variant P.1 in Traveler Returning from Brazil to Italy	41
Asymptomatic SARS-CoV-2 Infection in Nursing Homes, Barcelona, Spain, April 2020	40
Analysis of MarketScan Data for Immunosuppressive Conditions and Hospitalizations for Acute Respiratory Illness, United States	40
Psychobehavioral Responses and Likelihood of Receiving COVID-19 Vaccines during the Pandemic, Hong Kong	39
Role of Anopheles stephensi Mosquitoes in Malaria Outbreak, Djibouti, 2019	39
Outbreaks of Highly Pathogenic Avian Influenza (H5N6) Virus Subclade 2.3.4.4h in Swans, Xinjiang, Western China, 2020	39
Mass Mortality Caused by Highly Pathogenic Influenza A(H5N1) Virus in Sandwich Terns, the Netherlands, 2022	38
Potential Role of Social Distancing in Mitigating Spread of Coronavirus Disease, South Korea	38
Cross-Sectional Serosurvey of Companion Animals Housed with SARS-CoV-2–Infected Owners, Italy	38
Clade I–Associated Mpox Cases Associated with Sexual Contact, the Democratic Republic of the Congo	37
Differential Yellow Fever Susceptibility in New World Nonhuman Primates, Comparison with Humans, and Implications for Surveillance	37
Industry Sectors Highly Affected by Worksite Outbreaks of Coronavirus Disease, Los Angeles County, California, USA, March 19–September 30, 2020	37
Rapid Detection of SARS-CoV-2 Variants of Concern, Including B.1.1.28/P.1, British Columbia, Canada	36
Foodborne Illness Outbreaks Reported to National Surveillance, United States, 2009–2018	36
Symptom Profiles and Progression in Hospitalized and Nonhospitalized Patients with Coronavirus Disease, Colorado, USA, 2020	36
Pertactin-DeficientBordetella pertussis, Vaccine-Driven Evolution, and Reemergence of Pertussis	36
Serologic Responses in Healthy Adult with SARS-CoV-2 Reinfection, Hong Kong, August 2020	36
CrAssphage as a Novel Tool to Detect Human Fecal Contamination on Environmental Surfaces and Hands	36
Risk for Fomite-Mediated Transmission of SARS-CoV-2 in Child Daycares, Schools, Nursing Homes, and Offices	36
Genomic Characterization of Respiratory Syncytial Virus during 2022–23 Outbreak, Washington, USA	35
Introduction of ORF3a-Q57H SARS-CoV-2 Variant Causing Fourth Epidemic Wave of COVID-19, Hong Kong, China	35
Direct and Indirect Effectiveness of mRNA Vaccination against Severe Acute Respiratory Syndrome Coronavirus 2 in Long-Term Care Facilities, Spain	35
Role of Oral Rabies Vaccines in the Elimination of Dog-Mediated Human Rabies Deaths	35
Linezolid-Associated Neurologic Adverse Events in Patients with Multidrug-Resistant Tuberculosis, France	35
Listeriosis Caused by Persistence of Listeria monocytogenes Serotype 4b Sequence Type 6 in Cheese Production Environment	35
Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 IgG in Juba, South Sudan, 20201	35
Acute Cerebral Stroke with Multiple Infarctions and COVID-19, France, 2020	35
Possible Human-to-Dog Transmission of SARS-CoV-2, Italy, 2020	35
Breakthrough Infections of SARS-CoV-2 Gamma Variant in Fully Vaccinated Gold Miners, French Guiana, 2021	34
Epidemiology of COVID-19 Outbreak on Cruise Ship Quarantined at Yokohama, Japan, February 2020	34
Coccidioidomycosis and COVID-19 Co-Infection, United States, 2020	34
SARS-CoV-2–Specific Antibodies in Domestic Cats during First COVID-19 Wave, Europe	34
Epidemiologic, Clinical, and Genetic Characteristics of Human Infections with Influenza A(H5N6) Viruses, China	34
Association between Shiga Toxin–Producing Escherichia coli O157:H7 stx Gene Subtype and Disease Severity, England, 2009–2019	34
Risk-Based Estimate of Human Fungal Disease Burden, China	34
Prevalence of SARS-CoV-2 Antibodies in First Responders and Public Safety Personnel, New York City, New York, USA, May–July 2020	33
Strand-Specific Reverse Transcription PCR for Detection of Replicating SARS-CoV-2	33
Intrauterine Transmission of SARS-CoV-2	33
Novel Hendra Virus Variant Detected by Sentinel Surveillance of Horses in Australia	33
Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020	33
Monkeypox Virus Transmission to Healthcare Worker through Needlestick Injury, Brazil	33
Analysis of Asymptomatic and Presymptomatic Transmission in SARS-CoV-2 Outbreak, Germany, 2020	33
Severe Acute Respiratory Syndrome Coronavirus 2 Seropositivity among Healthcare Personnel in Hospitals and Nursing Homes, Rhode Island, USA, July–August 2020	33
Attribution of Illnesses Transmitted by Food and Water to Comprehensive Transmission Pathways Using Structured Expert Judgment, United States	33
Detecting Rapid Spread of SARS-CoV-2 Variants, France, January 26–February 16, 2021	32
SARS-CoV-2 Phylogenetic Analysis, Lazio Region, Italy, February–March 2020	32
Rapid Spread of Severe Fever with Thrombocytopenia Syndrome Virus by Parthenogenetic Asian Longhorned Ticks	32
Lyssaviruses in Insectivorous Bats, South Africa, 2003–2018	32
Global Estimate of Human Brucellosis Incidence	32
Operating Protocols of a Community Treatment Center for Isolation of Patients with Coronavirus Disease, South Korea	32
Four Patients with COVID-19 and Tuberculosis, Singapore, April–May 2020	32
Rising Incidence of Legionnaires’ Disease and Associated Epidemiologic Patterns, United States, 1992–2018	32
Effects of Social Distancing Measures during the First Epidemic Wave of Severe Acute Respiratory Syndrome Infection, Greece	32
Comparative Effectiveness of Coronavirus Vaccine in Preventing Breakthrough Infections among Vaccinated Persons Infected with Delta and Alpha Variants	32
Unique Outbreak of Rift Valley Fever in Sudan, 2019	31
Human Tacheng Tick Virus 2 Infection, China, 2019	31
Plasmodium cynomolgi Co-infections among Symptomatic Malaria Patients, Thailand	31
Iceland as Stepping Stone for Spread of Highly Pathogenic Avian Influenza Virus between Europe and North America	31
IgG Seroconversion and Pathophysiology in Severe Acute Respiratory Syndrome Coronavirus 2 Infection	31
Pooling Upper Respiratory Specimens for Rapid Mass Screening of COVID-19 by Real-Time RT-PCR	31
Seasonality of Common Human Coronaviruses, United States, 2014–20211	30
Seroprevalence of SARS-CoV-2–Specific Antibodies, Faroe Islands	30
Postmortem Stability of SARS-CoV-2 in Nasopharyngeal Mucosa	30
Severe Acute Respiratory Syndrome Coronavirus 2 Transmission Potential, Iran, 2020	30
Severe Acute Respiratory Syndrome Coronavirus 2 in Farmed Mink (Neovison vison), Poland	30
Trends in Population Dynamics ofEscherichia coliSequence Type 131, Calgary, Alberta, Canada, 2006–20161	30
Natural Plasmodium inui Infections in Humans and Anopheles cracens Mosquito, Malaysia	30
Real-Time Genomics for Tracking Severe Acute Respiratory Syndrome Coronavirus 2 Border Incursions after Virus Elimination, New Zealand	30
Retrospective Description of Pregnant Women Infected with Severe Acute Respiratory Syndrome Coronavirus 2, France	29
COVID-19 and Fatal Sepsis Caused by Hypervirulent Klebsiella pneumoniae, Japan, 2020	29
Large SARS-CoV-2 Outbreak Caused by Asymptomatic Traveler, China	29
Serial Interval and Transmission Dynamics during SARS-CoV-2 Delta Variant Predominance, South Korea	29
Serial Interval and Incubation Period Estimates of Monkeypox Virus Infection in 12 Jurisdictions, United States, May–August 2022	29
Twenty-Year Public Health Impact of 7- and 13-Valent Pneumococcal Conjugate Vaccines in US Children	29
SARS-CoV-2 Outbreak among Malayan Tigers and Humans, Tennessee, USA, 2020	29
Risk Factors for SARS-CoV-2 Infection and Illness in Cats and Dogs1	29
Undetected Circulation of African Swine Fever in Wild Boar, Asia	29
Risk for SARS-CoV-2 Infection in Healthcare Workers, Turin, Italy	28
Detection of Monkeypox Virus DNA in Airport Wastewater, Rome, Italy	28
Use of Genomics to Track Coronavirus Disease Outbreaks, New Zealand	28